These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15518894)

  • 1. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
    Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
    Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
    Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
    J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
    Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
    Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
    Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.
    Reglodi D; Fábián Z; Tamás A; Lubics A; Szeberényi J; Alexy T; Tóth K; Márton Z; Borsiczky B; Rõth E; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):51-9. PubMed ID: 15518893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
    Nonaka N; Shioda S; Banks WA
    Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
    Shioda S; Ohtaki H; Nakamachi T; Dohi K; Watanabe J; Nakajo S; Arata S; Kitamura S; Okuda H; Takenoya F; Kitamura Y
    Ann N Y Acad Sci; 2006 Jul; 1070():550-60. PubMed ID: 16888224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
    Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
    Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
    Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
    Nowak JZ; Dejda A; Zawilska JB
    Pol J Pharmacol; 2001; 53(6):695-9. PubMed ID: 11985349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
    Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.
    Shimizu T; Katahira M; Sugawara H; Inoue K; Miyata A
    Regul Pept; 2004 Dec; 123(1-3):117-22. PubMed ID: 15518901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat.
    Yamauchi K; Murakami Y; Nishiki M; Tanaka J; Koshimura K; Kato Y
    Neurosci Lett; 1995 Apr; 189(2):131-4. PubMed ID: 7609919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.